Heart scan study aims to predict artery disease in High-Risk patients
NCT ID NCT07427472
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 300 adults aged 30–60 with genetically confirmed familial hypercholesterolemia, a condition causing very high cholesterol. Researchers use CT scans to see how coronary artery plaques change over 5 years. The goal is to better understand disease progression and identify those at highest risk.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Coronary computed tomography angiography (CCTA) with contrast dye
- What this could lead to
- If successful, this could help doctors better predict and monitor heart disease in people with familial hypercholesterolemia, leading to earlier interventions.
- What could go wrong
- This is an observational imaging study, not a treatment trial. It will not directly improve health, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HEFH) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
APHP- Hospital Saint-Antoine
NOT_YET_RECRUITINGParis, Île-de-France Region, 75013, France
-
APHP-Sorbonne, Pitié Salpêtrière Hospital
RECRUITINGParis, Île-de-France Region, 75013, France
-
Plateau d'investigation clinique (PIC) IHU-ICAN
NOT_YET_RECRUITINGParis, 75013, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.